In this issue:
Sleeve gastrectomy vs. semaglutide vs. tirzepatide at 1 year
EMBRAZE: tirzepatide + apitegromab for lean mass preservation
Appetite & energy intake after high-intensity exercise
Setmelanotide in acquired hypothalamic obesity
Cost-effectiveness of Roux-en-Y gastric bypass & sleeve gastrectomy in adolescent obesity
Oral vs. subcutaneous semaglutide in obesity
TREAD: time-restricted eating in obesity
VISTA: elecoglipron (oral small molecule GLP-1 RA) in obesity
The AMPLIFY diet intervention for survivors of obesity-related cancers
An integrated model (OBSCORE) to stratify obesity risk
Please login below to download this issue (PDF)